Table:
begin	end	state
1	18	cytoplasmic
19	36	transmembrane
37	58	non-cytoplasmic
59	78	transmembrane
79	87	cytoplasmic
88	108	transmembrane
109	113	non-cytoplasmic
114	135	transmembrane
136	168	cytoplasmic
169	191	transmembrane
192	196	non-cytoplasmic
197	217	transmembrane
218	266	cytoplasmic
267	287	transmembrane
288	306	non-cytoplasmic
307	329	transmembrane
330	340	cytoplasmic
341	359	transmembrane
360	363	non-cytoplasmic
364	385	transmembrane
386	396	cytoplasmic
397	422	transmembrane
423	434	non-cytoplasmic
435	454	transmembrane
455	467	cytoplasmic

Input:
>GFF2889
MNLNEPINAHRVGQAVGNYRWTICAMLFFATTVNYLDRQVLSLLAPQLSTQFGWSNTDYA
NIAAVFQFVYAISMLFAGRFVDKIGTKAAYVVAIAIWSTGAIMHAFSVPMGEGIAAISGA
IGLAVIPVSIAGFMLSRAVLAIGEAGNFPIAIKATAEYFPKKERSLATGIFNSGANVGAI
LAPICVPLIAGLWGWEAAFIVIGGLGFVWVVVWIALYQKPEEQKRLSPEELAYIRSDQTV
QPFTPAPAGAPEKKVSWFKLLTYRQTWAFAFGKFMTDGVWWFFLFWLPTYLSAQYGMKGA
DIVMPLAVLYSMTMVGSIGGGWFPSYFMARGDAPYDGRMKAMLVIALFPLVVLLAQPLGY
ISFWVPVLLIGVGASAHQAWSCNIFTTVSDMFPQKTVASVVGIGGMAGGLGGVVMTKIGG
WVFDYYKSVGDIHTGYMIMFAICALAYLVAWSVMKTLVPRHKEITDL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server